GLP-1 and weight support with eligibility review and coaching

Average weight loss diverges by roughly six points. Side-effect profiles rhyme but aren't identical. Here's how to pick the molecule that fits your A1c, your GI tolerance, and what's actually stocked in your state - and when the answer is to start with labs instead of a prescription.

Ozempic and Wegovy are both semaglutide. Same injection, same dose strengths - but one is approved for type 2 diabetes and the other for chronic weight management. That labeling difference drives insurance coverage, supply, and who can prescribe what. Here is how to tell them apart before you waste a week calling your pharmacy.

Branded GLP-1s are FDA-approved and FDA-reviewed for efficacy. Compounded versions use the same pharmaceutical-grade peptide from a licensed compounding pharmacy, typically at 40-70% lower cost, without the same regulatory review. Both are legal in most states; both have real trade-offs. Here is how to pick without ending up on a Reddit-sourced vial from nowhere.

Oral semaglutide offers needle-free convenience, but injectable formulations still dominate weight-loss efficacy and dosing flexibility. This guide compares practical adherence, effect size, and who benefits most from each route.

Retatrutide is drawing attention for potent early trial signals, but tirzepatide remains the established clinical pathway with broader real-world use and availability. This comparison clarifies where evidence strength and access currently diverge.